Study reveals kidney disease or injury is associated with much higher risk of mortality for COVID-19 patients in ICU

https://www.eurekalert.org/pub_releases/2020-10/a-srk101620.php

News Release 16-Oct-2020
AAGBI

New research published in Anaesthesia (a journal of the Association of Anaesthetists) reveals the much higher risk of mortality faced by COVID-19 patients in intensive care who have chronic kidney disease (CKD) or, those who develop new (acute) kidney injury (AKI) as a result of developing COVID-19.

CKD is a type of kidney disease in which kidney function declines over a period of months to years, and is more common in older people. There are five stages of the disease, ranging from early stages (1 and 2) in which people initially have no symptoms, through to the more serious stages 3 to 5, which can be associated with complications such as high blood pressure, type 2 diabetes and heart disease. CKD stage 5 is termed end stage kidney failure which must be treated with either dialysis (at home or in hospital), involving complex filtering machinery that takes over the blood-cleaning functions of the kidneys, or with a kidney transplant.

AKI is an abrupt loss of kidney function that takes place over seven days or less, and can have several causes, including the damage and inflammation caused by the COVID-19 virus itself, loss of blood flow to the kidneys, damage from pharmaceutical drugs or other ingested/injected substances, or by anything obstructing the flow of urine in the urinary tract.

•••••